nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—TUBB—dilated cardiomyopathy	0.831	1	CbGaD
Ixabepilone—TUBB8—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00377	0.0489	CbGpPWpGaD
Ixabepilone—Hypovolaemia—Furosemide—dilated cardiomyopathy	0.00337	0.0485	CcSEcCtD
Ixabepilone—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00311	0.0403	CbGpPWpGaD
Ixabepilone—Metabolic acidosis—Furosemide—dilated cardiomyopathy	0.00265	0.038	CcSEcCtD
Ixabepilone—Atrial flutter—Lisinopril—dilated cardiomyopathy	0.00207	0.0297	CcSEcCtD
Ixabepilone—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00197	0.0283	CcSEcCtD
Ixabepilone—TUBB2B—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00191	0.0247	CbGpPWpGaD
Ixabepilone—TUBB6—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00191	0.0247	CbGpPWpGaD
Ixabepilone—TUBB3—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00184	0.0239	CbGpPWpGaD
Ixabepilone—Dysaesthesia—Lisinopril—dilated cardiomyopathy	0.00182	0.0261	CcSEcCtD
Ixabepilone—TUBB2A—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00178	0.0231	CbGpPWpGaD
Ixabepilone—TUBB1—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00174	0.0226	CbGpPWpGaD
Ixabepilone—TUBB—cardiac ventricle—dilated cardiomyopathy	0.0016	0.0709	CbGeAlD
Ixabepilone—TUBB2A—cardiac ventricle—dilated cardiomyopathy	0.00159	0.0705	CbGeAlD
Ixabepilone—TUBB6—cardiac ventricle—dilated cardiomyopathy	0.00157	0.0696	CbGeAlD
Ixabepilone—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00157	0.0204	CbGpPWpGaD
Ixabepilone—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00157	0.0204	CbGpPWpGaD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00156	0.0203	CbGpPWpGaD
Ixabepilone—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00152	0.0197	CbGpPWpGaD
Ixabepilone—TUBB—myocardium—dilated cardiomyopathy	0.00151	0.0667	CbGeAlD
Ixabepilone—TUBB2A—myocardium—dilated cardiomyopathy	0.0015	0.0664	CbGeAlD
Ixabepilone—TUBB6—myocardium—dilated cardiomyopathy	0.00148	0.0654	CbGeAlD
Ixabepilone—Thrombosis—Furosemide—dilated cardiomyopathy	0.00148	0.0212	CcSEcCtD
Ixabepilone—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00147	0.0191	CbGpPWpGaD
Ixabepilone—TUBB—Loss of Nlp from mitotic centrosomes—ALMS1—dilated cardiomyopathy	0.00146	0.0189	CbGpPWpGaD
Ixabepilone—TUBB4A—Loss of Nlp from mitotic centrosomes—TUBB—dilated cardiomyopathy	0.00144	0.0187	CbGpPWpGaD
Ixabepilone—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00144	0.0187	CbGpPWpGaD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00143	0.0186	CbGpPWpGaD
Ixabepilone—Lethargy—Spironolactone—dilated cardiomyopathy	0.00142	0.0205	CcSEcCtD
Ixabepilone—TUBB4B—cardiac ventricle—dilated cardiomyopathy	0.00137	0.0605	CbGeAlD
Ixabepilone—TUBB4B—Loss of Nlp from mitotic centrosomes—TUBB—dilated cardiomyopathy	0.00132	0.0171	CbGpPWpGaD
Ixabepilone—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.0013	0.0187	CcSEcCtD
Ixabepilone—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00129	0.0167	CbGpPWpGaD
Ixabepilone—TUBB—Centrosome maturation—ALMS1—dilated cardiomyopathy	0.00129	0.0167	CbGpPWpGaD
Ixabepilone—TUBB4B—myocardium—dilated cardiomyopathy	0.00129	0.0569	CbGeAlD
Ixabepilone—TUBB4A—Centrosome maturation—TUBB—dilated cardiomyopathy	0.00128	0.0166	CbGpPWpGaD
Ixabepilone—Gastritis—Spironolactone—dilated cardiomyopathy	0.00124	0.0177	CcSEcCtD
Ixabepilone—TUBB4A—Loss of Nlp from mitotic centrosomes—ALMS1—dilated cardiomyopathy	0.00121	0.0157	CbGpPWpGaD
Ixabepilone—TUBB—Regulation of PLK1 Activity at G2/M Transition—ALMS1—dilated cardiomyopathy	0.00118	0.0154	CbGpPWpGaD
Ixabepilone—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00118	0.0153	CbGpPWpGaD
Ixabepilone—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—TUBB—dilated cardiomyopathy	0.00117	0.0152	CbGpPWpGaD
Ixabepilone—TUBB8—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.00117	0.0152	CbGpPWpGaD
Ixabepilone—TUBB4B—Centrosome maturation—TUBB—dilated cardiomyopathy	0.00117	0.0151	CbGpPWpGaD
Ixabepilone—TUBB4A—heart—dilated cardiomyopathy	0.00115	0.0509	CbGeAlD
Ixabepilone—TUBB2B—heart—dilated cardiomyopathy	0.00111	0.0492	CbGeAlD
Ixabepilone—TUBB4B—Loss of Nlp from mitotic centrosomes—ALMS1—dilated cardiomyopathy	0.0011	0.0143	CbGpPWpGaD
Ixabepilone—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00109	0.0156	CcSEcCtD
Ixabepilone—Vasculitis—Furosemide—dilated cardiomyopathy	0.00107	0.0154	CcSEcCtD
Ixabepilone—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—TUBB—dilated cardiomyopathy	0.00107	0.0139	CbGpPWpGaD
Ixabepilone—TUBB4A—Centrosome maturation—ALMS1—dilated cardiomyopathy	0.00107	0.0139	CbGpPWpGaD
Ixabepilone—Renal failure—Spironolactone—dilated cardiomyopathy	0.00106	0.0152	CcSEcCtD
Ixabepilone—TUBB—heart—dilated cardiomyopathy	0.00105	0.0466	CbGeAlD
Ixabepilone—TUBB2A—heart—dilated cardiomyopathy	0.00105	0.0463	CbGeAlD
Ixabepilone—TUBB6—heart—dilated cardiomyopathy	0.00103	0.0457	CbGeAlD
Ixabepilone—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—ALMS1—dilated cardiomyopathy	0.000981	0.0127	CbGpPWpGaD
Ixabepilone—TUBB4B—Centrosome maturation—ALMS1—dilated cardiomyopathy	0.000978	0.0127	CbGpPWpGaD
Ixabepilone—TUBB2B—cardiac atrium—dilated cardiomyopathy	0.000951	0.0421	CbGeAlD
Ixabepilone—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000913	0.0131	CcSEcCtD
Ixabepilone—TUBB—cardiac atrium—dilated cardiomyopathy	0.0009	0.0398	CbGeAlD
Ixabepilone—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—ALMS1—dilated cardiomyopathy	0.000898	0.0117	CbGpPWpGaD
Ixabepilone—TUBB4B—heart—dilated cardiomyopathy	0.000897	0.0397	CbGeAlD
Ixabepilone—TUBB2A—cardiac atrium—dilated cardiomyopathy	0.000895	0.0396	CbGeAlD
Ixabepilone—TUBB—G2/M Transition—ALMS1—dilated cardiomyopathy	0.000889	0.0115	CbGpPWpGaD
Ixabepilone—TUBB6—cardiac atrium—dilated cardiomyopathy	0.000883	0.0391	CbGeAlD
Ixabepilone—TUBB4A—G2/M Transition—TUBB—dilated cardiomyopathy	0.000879	0.0114	CbGpPWpGaD
Ixabepilone—TUBB—Mitotic G2-G2/M phases—ALMS1—dilated cardiomyopathy	0.000877	0.0114	CbGpPWpGaD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—TUBB—dilated cardiomyopathy	0.000867	0.0113	CbGpPWpGaD
Ixabepilone—Alopecia—Spironolactone—dilated cardiomyopathy	0.000853	0.0123	CcSEcCtD
Ixabepilone—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000808	0.0116	CcSEcCtD
Ixabepilone—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000804	0.0116	CcSEcCtD
Ixabepilone—TUBB4B—G2/M Transition—TUBB—dilated cardiomyopathy	0.000804	0.0104	CbGpPWpGaD
Ixabepilone—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.000795	0.0114	CcSEcCtD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—TUBB—dilated cardiomyopathy	0.000793	0.0103	CbGpPWpGaD
Ixabepilone—Lethargy—Furosemide—dilated cardiomyopathy	0.000775	0.0111	CcSEcCtD
Ixabepilone—TUBB4B—cardiac atrium—dilated cardiomyopathy	0.000768	0.034	CbGeAlD
Ixabepilone—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000763	0.011	CcSEcCtD
Ixabepilone—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000753	0.0108	CcSEcCtD
Ixabepilone—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000737	0.0106	CcSEcCtD
Ixabepilone—TUBB4A—G2/M Transition—ALMS1—dilated cardiomyopathy	0.000737	0.00957	CbGpPWpGaD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—ALMS1—dilated cardiomyopathy	0.000727	0.00944	CbGpPWpGaD
Ixabepilone—Dehydration—Furosemide—dilated cardiomyopathy	0.000706	0.0101	CcSEcCtD
Ixabepilone—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000691	0.00993	CcSEcCtD
Ixabepilone—TUBB4B—G2/M Transition—ALMS1—dilated cardiomyopathy	0.000674	0.00875	CbGpPWpGaD
Ixabepilone—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000672	0.00965	CcSEcCtD
Ixabepilone—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00067	0.00962	CcSEcCtD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—ALMS1—dilated cardiomyopathy	0.000665	0.00863	CbGpPWpGaD
Ixabepilone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000592	0.00851	CcSEcCtD
Ixabepilone—TUBB6—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.000591	0.00767	CbGpPWpGaD
Ixabepilone—TUBB2B—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.000591	0.00767	CbGpPWpGaD
Ixabepilone—TUBB—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.000586	0.0076	CbGpPWpGaD
Ixabepilone—Renal failure—Furosemide—dilated cardiomyopathy	0.000575	0.00826	CcSEcCtD
Ixabepilone—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000572	0.00822	CcSEcCtD
Ixabepilone—TUBB3—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.000571	0.00741	CbGpPWpGaD
Ixabepilone—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000554	0.00795	CcSEcCtD
Ixabepilone—TUBB2A—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.000553	0.00718	CbGpPWpGaD
Ixabepilone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000542	0.00779	CcSEcCtD
Ixabepilone—TUBB1—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.00054	0.00702	CbGpPWpGaD
Ixabepilone—Dehydration—Lisinopril—dilated cardiomyopathy	0.00053	0.00761	CcSEcCtD
Ixabepilone—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000519	0.00745	CcSEcCtD
Ixabepilone—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000515	0.0074	CcSEcCtD
Ixabepilone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000506	0.00726	CcSEcCtD
Ixabepilone—Gastritis—Lisinopril—dilated cardiomyopathy	0.000504	0.00724	CcSEcCtD
Ixabepilone—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000497	0.00713	CcSEcCtD
Ixabepilone—Eye disorder—Furosemide—dilated cardiomyopathy	0.000491	0.00705	CcSEcCtD
Ixabepilone—Pruritus—Spironolactone—dilated cardiomyopathy	0.000485	0.00697	CcSEcCtD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.000485	0.0063	CbGpPWpGaD
Ixabepilone—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00048	0.00689	CcSEcCtD
Ixabepilone—Angiopathy—Furosemide—dilated cardiomyopathy	0.000477	0.00685	CcSEcCtD
Ixabepilone—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000475	0.00681	CcSEcCtD
Ixabepilone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000469	0.00674	CcSEcCtD
Ixabepilone—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000468	0.00672	CcSEcCtD
Ixabepilone—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000461	0.00661	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000458	0.00657	CcSEcCtD
Ixabepilone—Malnutrition—Furosemide—dilated cardiomyopathy	0.000457	0.00657	CcSEcCtD
Ixabepilone—Dizziness—Spironolactone—dilated cardiomyopathy	0.000454	0.00652	CcSEcCtD
Ixabepilone—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000446	0.0064	CcSEcCtD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.000444	0.00576	CbGpPWpGaD
Ixabepilone—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000442	0.00634	CcSEcCtD
Ixabepilone—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00044	0.00631	CcSEcCtD
Ixabepilone—Vomiting—Spironolactone—dilated cardiomyopathy	0.000436	0.00626	CcSEcCtD
Ixabepilone—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000433	0.00622	CcSEcCtD
Ixabepilone—Rash—Spironolactone—dilated cardiomyopathy	0.000433	0.00621	CcSEcCtD
Ixabepilone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000432	0.00621	CcSEcCtD
Ixabepilone—Renal failure—Lisinopril—dilated cardiomyopathy	0.000432	0.0062	CcSEcCtD
Ixabepilone—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00043	0.00618	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00043	0.00618	CcSEcCtD
Ixabepilone—Headache—Spironolactone—dilated cardiomyopathy	0.00043	0.00617	CcSEcCtD
Ixabepilone—Jaundice—Lisinopril—dilated cardiomyopathy	0.000428	0.00615	CcSEcCtD
Ixabepilone—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000427	0.00613	CcSEcCtD
Ixabepilone—Anaemia—Furosemide—dilated cardiomyopathy	0.000423	0.00607	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000415	0.00596	CcSEcCtD
Ixabepilone—Leukopenia—Furosemide—dilated cardiomyopathy	0.000409	0.00588	CcSEcCtD
Ixabepilone—Nausea—Spironolactone—dilated cardiomyopathy	0.000408	0.00585	CcSEcCtD
Ixabepilone—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000389	0.00559	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000387	0.00555	CcSEcCtD
Ixabepilone—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000386	0.00555	CcSEcCtD
Ixabepilone—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000373	0.00535	CcSEcCtD
Ixabepilone—Shock—Furosemide—dilated cardiomyopathy	0.000367	0.00527	CcSEcCtD
Ixabepilone—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000366	0.00526	CcSEcCtD
Ixabepilone—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000365	0.00525	CcSEcCtD
Ixabepilone—Skin disorder—Furosemide—dilated cardiomyopathy	0.000363	0.00521	CcSEcCtD
Ixabepilone—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000358	0.00514	CcSEcCtD
Ixabepilone—Anorexia—Furosemide—dilated cardiomyopathy	0.000356	0.00511	CcSEcCtD
Ixabepilone—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000355	0.0051	CcSEcCtD
Ixabepilone—Chills—Lisinopril—dilated cardiomyopathy	0.000354	0.00508	CcSEcCtD
Ixabepilone—Hypotension—Furosemide—dilated cardiomyopathy	0.000349	0.00501	CcSEcCtD
Ixabepilone—Alopecia—Lisinopril—dilated cardiomyopathy	0.000348	0.005	CcSEcCtD
Ixabepilone—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000345	0.00496	CcSEcCtD
Ixabepilone—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000343	0.00493	CcSEcCtD
Ixabepilone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000335	0.00481	CcSEcCtD
Ixabepilone—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00033	0.00474	CcSEcCtD
Ixabepilone—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000324	0.00466	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000322	0.00463	CcSEcCtD
Ixabepilone—Fatigue—Furosemide—dilated cardiomyopathy	0.000322	0.00462	CcSEcCtD
Ixabepilone—Pain—Furosemide—dilated cardiomyopathy	0.000319	0.00458	CcSEcCtD
Ixabepilone—Constipation—Furosemide—dilated cardiomyopathy	0.000319	0.00458	CcSEcCtD
Ixabepilone—Anaemia—Lisinopril—dilated cardiomyopathy	0.000317	0.00455	CcSEcCtD
Ixabepilone—Syncope—Lisinopril—dilated cardiomyopathy	0.000308	0.00442	CcSEcCtD
Ixabepilone—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000307	0.00441	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000305	0.00438	CcSEcCtD
Ixabepilone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000302	0.00433	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.000301	0.00391	CbGpPWpGaD
Ixabepilone—Cough—Lisinopril—dilated cardiomyopathy	0.000299	0.0043	CcSEcCtD
Ixabepilone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000295	0.00424	CcSEcCtD
Ixabepilone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000295	0.00424	CcSEcCtD
Ixabepilone—Chest pain—Lisinopril—dilated cardiomyopathy	0.000292	0.0042	CcSEcCtD
Ixabepilone—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000292	0.0042	CcSEcCtD
Ixabepilone—Myalgia—Lisinopril—dilated cardiomyopathy	0.000292	0.0042	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00029	0.00417	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.000283	0.00367	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000281	0.00365	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000281	0.00365	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000281	0.00365	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000281	0.00365	CbGpPWpGaD
Ixabepilone—Oedema—Lisinopril—dilated cardiomyopathy	0.00028	0.00402	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.00028	0.00363	CbGpPWpGaD
Ixabepilone—Infection—Lisinopril—dilated cardiomyopathy	0.000278	0.004	CcSEcCtD
Ixabepilone—Shock—Lisinopril—dilated cardiomyopathy	0.000276	0.00396	CcSEcCtD
Ixabepilone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000275	0.00395	CcSEcCtD
Ixabepilone—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000274	0.00394	CcSEcCtD
Ixabepilone—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000272	0.00391	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000271	0.00352	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000271	0.00352	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—EMD—dilated cardiomyopathy	0.000269	0.00349	CbGpPWpGaD
Ixabepilone—Asthenia—Furosemide—dilated cardiomyopathy	0.000268	0.00385	CcSEcCtD
Ixabepilone—Anorexia—Lisinopril—dilated cardiomyopathy	0.000267	0.00383	CcSEcCtD
Ixabepilone—Pruritus—Furosemide—dilated cardiomyopathy	0.000264	0.00379	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000263	0.00341	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000263	0.00341	CbGpPWpGaD
Ixabepilone—Hypotension—Lisinopril—dilated cardiomyopathy	0.000262	0.00376	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000257	0.00333	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000257	0.00333	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.000256	0.00332	CbGpPWpGaD
Ixabepilone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000255	0.00367	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000255	0.00366	CcSEcCtD
Ixabepilone—Insomnia—Lisinopril—dilated cardiomyopathy	0.000253	0.00364	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—ALMS1—dilated cardiomyopathy	0.000253	0.00328	CbGpPWpGaD
Ixabepilone—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000251	0.00361	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—TUBB—dilated cardiomyopathy	0.00025	0.00325	CbGpPWpGaD
Ixabepilone—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00025	0.00359	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.000249	0.00324	CbGpPWpGaD
Ixabepilone—Dizziness—Furosemide—dilated cardiomyopathy	0.000247	0.00354	CcSEcCtD
Ixabepilone—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000243	0.0035	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000242	0.00347	CcSEcCtD
Ixabepilone—Fatigue—Lisinopril—dilated cardiomyopathy	0.000241	0.00347	CcSEcCtD
Ixabepilone—Constipation—Lisinopril—dilated cardiomyopathy	0.00024	0.00344	CcSEcCtD
Ixabepilone—Pain—Lisinopril—dilated cardiomyopathy	0.00024	0.00344	CcSEcCtD
Ixabepilone—Vomiting—Furosemide—dilated cardiomyopathy	0.000237	0.00341	CcSEcCtD
Ixabepilone—Rash—Furosemide—dilated cardiomyopathy	0.000235	0.00338	CcSEcCtD
Ixabepilone—Dermatitis—Furosemide—dilated cardiomyopathy	0.000235	0.00338	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.000234	0.00304	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000234	0.00304	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000234	0.00304	CbGpPWpGaD
Ixabepilone—Headache—Furosemide—dilated cardiomyopathy	0.000234	0.00336	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000231	0.00299	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000231	0.00299	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000229	0.00329	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—TUBB—dilated cardiomyopathy	0.000229	0.00297	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.000228	0.00296	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000228	0.00296	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000228	0.00296	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000228	0.00296	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000228	0.00296	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000226	0.00294	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—EMD—dilated cardiomyopathy	0.000223	0.00289	CbGpPWpGaD
Ixabepilone—Nausea—Furosemide—dilated cardiomyopathy	0.000222	0.00318	CcSEcCtD
Ixabepilone—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000221	0.00318	CcSEcCtD
Ixabepilone—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000221	0.00318	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00022	0.00286	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00022	0.00286	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000219	0.00284	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.000214	0.00278	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000214	0.00278	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000213	0.00277	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000213	0.00277	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000212	0.00275	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000212	0.00275	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000211	0.00274	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000211	0.00274	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—ALMS1—dilated cardiomyopathy	0.00021	0.00272	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000208	0.0027	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000208	0.0027	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000206	0.00296	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000205	0.00266	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—EMD—dilated cardiomyopathy	0.000204	0.00265	CbGpPWpGaD
Ixabepilone—Asthenia—Lisinopril—dilated cardiomyopathy	0.000201	0.00289	CcSEcCtD
Ixabepilone—Pruritus—Lisinopril—dilated cardiomyopathy	0.000198	0.00285	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000198	0.00257	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000194	0.00251	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000192	0.0025	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—ALMS1—dilated cardiomyopathy	0.000192	0.00249	CbGpPWpGaD
Ixabepilone—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000192	0.00275	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000187	0.00243	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000187	0.00243	CbGpPWpGaD
Ixabepilone—Dizziness—Lisinopril—dilated cardiomyopathy	0.000185	0.00266	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.000179	0.00232	CbGpPWpGaD
Ixabepilone—Vomiting—Lisinopril—dilated cardiomyopathy	0.000178	0.00256	CcSEcCtD
Ixabepilone—Rash—Lisinopril—dilated cardiomyopathy	0.000177	0.00254	CcSEcCtD
Ixabepilone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000176	0.00253	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000176	0.00228	CbGpPWpGaD
Ixabepilone—Headache—Lisinopril—dilated cardiomyopathy	0.000175	0.00252	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000174	0.00226	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000171	0.00222	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000171	0.00222	CbGpPWpGaD
Ixabepilone—Nausea—Lisinopril—dilated cardiomyopathy	0.000166	0.00239	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—TMPO—dilated cardiomyopathy	0.00016	0.00208	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000159	0.00206	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.000148	0.00193	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.000147	0.00191	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.000136	0.00176	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TMPO—dilated cardiomyopathy	0.000133	0.00172	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—LMNA—dilated cardiomyopathy	0.000131	0.00171	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.000122	0.00158	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TMPO—dilated cardiomyopathy	0.000121	0.00157	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.000111	0.00145	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000111	0.00143	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000111	0.00143	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—LMNA—dilated cardiomyopathy	0.000109	0.00141	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000107	0.00139	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000103	0.00134	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000101	0.00131	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—LMNA—dilated cardiomyopathy	9.96e-05	0.00129	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—ACE—dilated cardiomyopathy	9.54e-05	0.00124	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—ACE—dilated cardiomyopathy	9.54e-05	0.00124	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—ACE—dilated cardiomyopathy	9.21e-05	0.0012	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—LMNA—dilated cardiomyopathy	9.08e-05	0.00118	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—ACE—dilated cardiomyopathy	8.92e-05	0.00116	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—ACE—dilated cardiomyopathy	8.73e-05	0.00113	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—LMNA—dilated cardiomyopathy	8.3e-05	0.00108	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—ACE—dilated cardiomyopathy	7.83e-05	0.00102	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—ACE—dilated cardiomyopathy	7.17e-05	0.00093	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—AGT—dilated cardiomyopathy	6.05e-05	0.000785	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—AGT—dilated cardiomyopathy	6.05e-05	0.000785	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—AGT—dilated cardiomyopathy	5.84e-05	0.000758	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—AGT—dilated cardiomyopathy	5.66e-05	0.000735	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—AGT—dilated cardiomyopathy	5.53e-05	0.000718	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—AGT—dilated cardiomyopathy	4.97e-05	0.000645	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.62e-05	0.0006	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.62e-05	0.0006	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—AGT—dilated cardiomyopathy	4.54e-05	0.00059	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.46e-05	0.000579	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.32e-05	0.000561	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.22e-05	0.000549	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.79e-05	0.000492	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.47e-05	0.00045	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.16e-05	0.000281	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.03e-05	0.000264	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.84e-05	0.000239	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5e-06	6.49e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.87e-06	6.32e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.38e-06	5.69e-05	CbGpPWpGaD
